Faculty

Institution

Unit

Venue

Lynne Shinto, N.D., M.P.H.

Professor of Neurology

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Center Of Layton Aging And Alzheimer'S Disease

Department Of Pediatrics

Division Of Neurology

Oregon Health & Science University

Lynne Shinto, N.d., M.p.h. is currently serving as a Center Of Layton Aging And Alzheimer'S Disease Professor of Neurology at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lynne Shinto, N.D., M.P.H.

Oregon Health & Science University

Professor of Neurology

You can click a keyword to filter the displayed items

neurology health sciences multiple sclerosis medicine pharmacology neurological progress alzheimer's disease complementary medicine alternative medicine omega-3 fatty acids dementia neurological disorders neurorehabilitation mental health mindfulness neurodegenerative diseases symptom management white matter lipids neuroimmunology psychological medicine neuroscience of aging integrative medicine experimental medicine clinical lipidology clinical nutrition respiratory medicine mindfulness interventions stress management clinical neurology cognitive decline neuropsychological rehabilitation neuropsychopharmacology nutritional biochemistry cell metabolism pain research brain health mind-body medicine lipid nutrition pain syndromes hyperlipidemia geriatric endocrinology lipoic acid older adults randomized pilot study cognitive rehabilitation aging-associated diseases memory loss stress biomarkers treatment development homeopathy medical nutrition anti-cancer agents drug targeting pharmacokinetics pharmacological studies later adulthood cell migration immune dysregulation mind-body interventions patient satisfaction nutritional epidemiology executive function clinical gerontology alzheimer disease docosahexaenoic acid supplementation alpha lipoic acid mild cognitive impairment nutritional biomarkers dementia severity matrix metalloproteinase-9 production relapsing-remitting multiple sclerosis survey burden promis measures research priorities wellness research

Notable Scholarly Works

Notable Federal Grants

Collaborators

Ω-3 Pufa for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults. JAMA Network Open (2024)

Lynne H. ShintoCharles F. MurchisonLisa C. SilbertHiroko H. DodgeDavid LahnaWilliam RooneyJeffrey KayeJoseph F. QuinnGene L. Bowman

white matter lesionssecondary preventionolder adultswhite matterneuronal integrity breakdownhealth sciences

Recovery of Motor Function is Associated With Rescue of Glutamate Biomarkers in the Striatum and Motor Cortex Following Treatment With Mucuna Pruriens in a Murine Model of Parkinsons Disease. Molecular and Cellular Neuroscience (2023)

dopaminemurine modelneuropharmacologyneurodegenerative diseasesneuronsneurorehabilitationparkinsons diseaseneuroscienceparkinson's diseasemovement disordersneurotransmittersglutamate biomarkersneurologyneurophysiologyneuropsychopharmacology

A Review of Oxylipins in Alzheimer’s Disease and Related Dementias (Adrd): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation. Metabolites (2022)

cerebral blood flowalzheimer's diseaseneurodegenerative diseasespharmacologyfree radical biologylipidslipid peroxidationvascular tonemolecular neurodegenerationneurologyneurochemical biomarkersdementiapotential therapeutic targetsbiochemistryvascular biologyvascular cognitive disorderclinical lipidologyneuroscience of agingpharmacological research

Randomized Trial of N‐3 Pufa for Cerebral White Matter Hyperintensities, Medial Temporal Lobe Atrophy and White Matter Integrity in Older Non‐Demented Adults: Per‐Protocol and Apoe Stratified Results. Alzheimer s & Dementia (2021)

Gene L BowmanCharles F MurchisonLisa C SilbertHiroko H DodgeKirsten HagenDavid LahnaWilliam S HarrisJeffrey A KayeJoseph F QuinnLynne Shinto

alzheimer's diseasedementiageriatricswhite matter integrityneurosciencegeriatric medicinepharmacologyolder non-demented adultsneurology

Docosahexaenoic Acid Oxylipins Are Associated With White Matter Microstructural Integrity in a Cohort of Cognitively Normal, Hypertensive Young‐Old. Alzheimer s & Dementia (2020)

hypertensive young‐oldneurodegenerative diseasespharmacologyneurologyhealth sciencesdocosahexaenoic acid oxylipins

Effects of Omega‐3 Fatty Acids on Cerebral White Matter Hyperintensities and Medial Temporal Lobe Atrophy in Older Non‐Demented Adults: A 3‐Year Randomized‐Controlled Phase 2 Trial. Alzheimer s & Dementia (2020)

Gene L BowmanLisa C SilbertHiroko H DodgeKirsten HagenJason C DavidCharles F MurchisonDavid LahnaJeffrey KayeJoseph F QuinnLynne Shinto

alzheimer's diseasegeriatricsdementianeuroscienceolder non-demented adultsneurologyomega-3 fatty acidshealth sciences

Health Behaviors, Wellness, and Multiple Sclerosis Amid Covid-19. Archives of Physical Medicine and Rehabilitation (2020)

Robert MotlDawn EhdeLynne ShintoBo FernhallNicholas LaRoccaKathleen Zackowski

covid-19medicinewellnesspublic healthhealth behaviorsmultiple sclerosisrehabilitationphysical medicine

Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated With Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults. Journal of Alzheimer s Disease (2020)

Lynne ShintoDavid LahnaCharles F. MurchisonHiroko DodgeKirsten HagenJason DavidJeffrey KayeJoseph F. QuinnRachel WallLisa C. Silbert

oxidized productsexecutive functionalzheimer's diseaseendocrinologygeriatricsgeriatric endocrinologyneurosciencehypertensionpharmacologyhyperlipidemiaclinical gerontologyhealth sciences

Qualitative Analysis of the Meals, Mindfulness, Moving Forward (M 3 ) Lifestyle Programme: Cultivating a ‘Safe Space’ to Start on a ‘New Path’ for Youth With Early Episode Psychosis. Early Intervention in Psychiatry (2020)

Andie ThompsonAngela SendersCeleste SeibelCraigan UsherAlena BorgattiKatheryn BoddenCarlo CalabreseKirsten HagenJason DavidDennis BourdetteLynne Shinto

psychiatrymental health interventionsearly episode psychosischild psychiatrymental healthchild mental healthmindfulnessqualitative researchadolescent healthadolescent psychology

Natural Product Target Network Reveals Potential for Cancer Combination Therapies. Frontiers in Pharmacology (2019)

anti-cancer agentscancer researchpharmacologycancer discoverytherapeutic targetsdrug targetingdrug discovery

1
2
3
4
5
6
10 / page

Lynne Shinto, N.D., M.P.H.

Professor of Neurology

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Center Of Layton Aging And Alzheimer'S Disease

Department Of Pediatrics

Division Of Neurology

Oregon Health & Science University

Lynne Shinto, N.d., M.p.h. is currently serving as a Center Of Layton Aging And Alzheimer'S Disease Professor of Neurology at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lynne Shinto, N.D., M.P.H.

Oregon Health & Science University

Professor of Neurology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Ω-3 Pufa for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults. JAMA Network Open (2024)

Lynne H. ShintoCharles F. MurchisonLisa C. SilbertHiroko H. DodgeDavid LahnaWilliam RooneyJeffrey KayeJoseph F. QuinnGene L. Bowman

white matter lesionssecondary preventionolder adultswhite matterneuronal integrity breakdownhealth sciences

A Review of Oxylipins in Alzheimer’s Disease and Related Dementias (Adrd): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation. Metabolites (2022)

Gene L BowmanCharles F MurchisonLisa C SilbertHiroko H DodgeKirsten HagenDavid LahnaWilliam S HarrisJeffrey A KayeJoseph F QuinnLynne Shinto

alzheimer's diseasedementiageriatricswhite matter integrityneurosciencegeriatric medicinepharmacologyolder non-demented adultsneurology

Docosahexaenoic Acid Oxylipins Are Associated With White Matter Microstructural Integrity in a Cohort of Cognitively Normal, Hypertensive Young‐Old. Alzheimer s & Dementia (2020)

hypertensive young‐oldneurodegenerative diseasespharmacologyneurologyhealth sciencesdocosahexaenoic acid oxylipins

Gene L BowmanLisa C SilbertHiroko H DodgeKirsten HagenJason C DavidCharles F MurchisonDavid LahnaJeffrey KayeJoseph F QuinnLynne Shinto

alzheimer's diseasegeriatricsdementianeuroscienceolder non-demented adultsneurologyomega-3 fatty acidshealth sciences

Health Behaviors, Wellness, and Multiple Sclerosis Amid Covid-19. Archives of Physical Medicine and Rehabilitation (2020)

Robert MotlDawn EhdeLynne ShintoBo FernhallNicholas LaRoccaKathleen Zackowski

covid-19medicinewellnesspublic healthhealth behaviorsmultiple sclerosisrehabilitationphysical medicine

Lynne ShintoDavid LahnaCharles F. MurchisonHiroko DodgeKirsten HagenJason DavidJeffrey KayeJoseph F. QuinnRachel WallLisa C. Silbert

oxidized productsexecutive functionalzheimer's diseaseendocrinologygeriatricsgeriatric endocrinologyneurosciencehypertensionpharmacologyhyperlipidemiaclinical gerontologyhealth sciences

Andie ThompsonAngela SendersCeleste SeibelCraigan UsherAlena BorgattiKatheryn BoddenCarlo CalabreseKirsten HagenJason DavidDennis BourdetteLynne Shinto

psychiatrymental health interventionsearly episode psychosischild psychiatrymental healthchild mental healthmindfulnessqualitative researchadolescent healthadolescent psychology

Natural Product Target Network Reveals Potential for Cancer Combination Therapies. Frontiers in Pharmacology (2019)

anti-cancer agentscancer researchpharmacologycancer discoverytherapeutic targetsdrug targetingdrug discovery

1
2
3
4
5
6
10 / page